Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Meningioma × fludarabine × Clear all

Phase

Status

Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 41 Precursor Cell Lymphoblastic Leukemia-Lymphoma 27 Myelodysplastic Syndromes 25 Lymphoma, Non-Hodgkin 20 Lymphoma 18 Hematologic Neoplasms 18 Multiple Myeloma 17 Lymphoma, B-Cell 15 Lymphoma, Large B-Cell, Diffuse 13 Leukemia, Lymphocytic, Chronic, B-Cell 12 Recurrence 11 Lymphoma, Follicular 11 Burkitt Lymphoma 11 Pancreatic Neoplasms 10 Myeloproliferative Disorders 10 Breast Neoplasms 10 Melanoma 9 Ovarian Neoplasms 8 Lymphoma, Mantle-Cell 8 Lymphoma, B-Cell, Marginal Zone 8 Leukemia, Myelomonocytic, Chronic 8 Leukemia, Biphenotypic, Acute 8 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 7 Stomach Neoplasms 6 Leukemia 6 Hodgkin Disease 6 Colorectal Neoplasms 6 Osteosarcoma 5 Neoplasm, Residual 5 Neoplasm Metastasis 5

Interventions

Magnetic Resonance Spectroscopy 6 lutetium Lu 177 dotatate 5 Specimen Handling 4 Proton Therapy 3 Everolimus 3 pembrolizumab 2 gallium Ga 68 dotatate 2 abemaciclib 2 Sunitinib 2 Radiosurgery 2 Protons 2 Observation 2 Hydroxyurea 2 Ga(III)-DOTATOC 2 Elasticity Imaging Techniques 2 Bevacizumab 2 trametinib 1 regorafenib 1 olaparib 1 fludarabine 1 dexamethasone acetate 1 dexamethasone 21-phosphate 1 capivasertib 1 cabozantinib 1 auricularum 1 apatinib 1 X-Rays 1 Watchful Waiting 1 Thrombectomy 1 Tablets 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06640582 2024-11-05

BAH2472

Essen Biotech

Phase 1/2 Recruiting

Brain Neoplasms, Glioblastoma, Glioma, Meningioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡